ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma

Zhong, Rong; Zhan, Jiandong; Zhang, Siyi*广东省人民医院
Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology2023-10-4DOI: 10.1007/s12010-023-04727-z
11阅读
引用收藏
分享

摘要

Stanniocalcin 2 (STC2) is involved in many tumour types, but it remains unclear what its biological function is in laryngeal squamous cell carcinoma (LSCC). Therefore, we investigated STC2's expression, potential function, and prognostic significance of in LSCC. The expression and prognosis of STC2 in LSCC were described using the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. In the TCGA database, the relationship between STC2 and immune infiltration, expression of immune cell chemokine and receptor genes, immune cell molecular marker genes, and epithelial-mesenchymal transition (EMT) marker genes were analysed. The biological processes involved in STC2 and its expression-related genes were analysed comprehensively using bioinformatics. The single-gene ceRNA network of STC2 was constructed in the TCGA database. Finally, LSCC patients' tumour tissue STC2 expression was verified. STC2 silencing with the RNAi technique was used for the determination of cellular functions in a laryngeal cancer cell line. STC2 expression was higher in most tumours, including LSCC, than in normal tissues and was associated with poor prognosis. The relative proportions of naive B, plasma, follicular helper T, and macrophage M0 cells in LSCC and normal samples differed significantly. STC2 expression correlated significantly positively with that of TGFB1 (biomarker of Tregs) and significantly negatively with that of D79A and CD19 (biomarkers of B cells). Furthermore, STC2 affected chemokine and receptor gene expression in immune cells. STC2 expression correlated with EMT marker gene expression in LSCC. STC2 was enriched in the PI3K/AKT signalling pathway, extracellular matrix (ECM) organisation, ECM-receptor interaction, and other tumour-related signalling pathways. STC2 was highly expressed in our clinical samples. N-cadherin and vimentin expression were decreased in the TU686 cell line after successful silencing of STC2, indicating that high STC2 expression may prompt LSCC cells to adopt a mesenchymal cell phenotype. STC2 silencing substantially reduced proliferation and migration in the TU686 cell line. STC2 may be a promising predictive biomarker for tumours, providing new approaches for LSCC diagnosis and treatment monitoring.

学科与关键词

关键词
Laryngeal squamous cell carcinomaSTC2The Cancer Genome Atlas (TCGA) databasesBioinformaticsPatient-derived organoidsPrognostic biomarker
相关
加载中…
  • Heterogeneity analysis of the immune microenvironment in laryngeal carcinoma revealed potential prognostic biomarkers
    Qian, Zhipeng; Shang, Desi; Fan, Lin; Zhang, Jiarui; Ji, Linhao; Chen, Kexin; Zhao, Rui*Human Molecular Genetics, 2022, 31(9): 1487-1499.被引 5
  • Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma
    Li, M.; An, J.; Ren, H.; Gui, J.; Wang, H.; Wu, S.; Wu, R.; Xiao, H.*; Wang, L.Bulletin of Experimental Biology and Medicine, 2023.
  • Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/TGFBR2 axis, promoting metastasis in laryngeal cancer
    Li, Yun; Tang, Bingjie; Lyu, Kexing; Yue, Huijun; Wei, Fanqin; Xu, Yang; Chen, Siyu; Lin, Yu; Cai, Zhimou; Guo, Xueqin; Li, Chunwei*; Lei, Wenbin*Molecular Carcinogenesis, 2022, 61(1): 45-58.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology
发表日期
2023-10-04
DOI
10.1007/s12010-023-04727-z
语言
ENGLISH
成果收录
SCIE
资助标注
Guangzhou Municipal Science and Technology Project [202002020024]

作者

  • Z

    Zhong, Rong (第一作者)

  • Z

    Zhan, Jiandong

    guangdong prov peoples hosp

查看全部 3 位作者收起作者
  • Z

    Zhang, Siyi (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417